MGP Ingredients
Stock Forecast, Prediction & Price Target
MGP Ingredients (MGPI) stock Price Target by analysts
$85
Potential upside: 190.00%
MGP Ingredients price prediction

What is MGP Ingredients stock analysts` prediction?
MGP Ingredients stock forecast: Based on 2 Wall Street analysts` predicted price targets for MGP Ingredients in the last 3 months, the avarage price target is $85, with a high forecast of $NaN. The average price target represents a 190.00% change from the last price of $29.31.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
MGP Ingredients stock Price Target by analysts
Full breakdown of analysts given MGP Ingredients price targets
Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
---|---|---|---|---|---|---|
Bill Chappell Truist Financial | 0% 0/4 | 11 months ago | $85 190.00% upside | $58.66 | StreetInsider | Previous targets (3) |
Ben Klieve Loop Capital Markets | 0% 0/2 | 11 months ago | $75 155.88% upside | $60.17 | StreetInsider | Previous targets (1) |
Bill Chappell Truist Financial | 0% 0/4 | 11 months ago | $95 224.12% upside | $80.87 | TheFly | Previous targets (3) |
Ben Klieve Loop Capital Markets | 0% 0/2 | about 1 year ago | $135 360.59% upside | $73.05 | StreetInsider | Previous targets (1) |
MGP Ingredients Wedbush | 0% 0/1 | about 1 year ago | $120 309.41% upside | $74.4 | TheFly | Previous targets (0) |
Bill Chappell Truist Financial | 0% 0/4 | about 2 years ago | $140 377.65% upside | $122.5 | Benzinga | Previous targets (3) |
Bill Chappell Truist Financial | 0% 0/4 | about 2 years ago | $125 326.47% upside | $113.95 | Benzinga | Previous targets (3) |
Unknown Wells Fargo | N/A | over 2 years ago | $118 302.59% upside | $97.87 | Benzinga | N/A |
MGP Ingredients Financial Estimates
MGP Ingredients Revenue Estimates
MGP Ingredients EBITDA Estimates
MGP Ingredients Earnings per Share Estimates
Passed | Analyst forecast | ||||||
---|---|---|---|---|---|---|---|
Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | ||
Revenue
% change YoY
| $626.72M N/A | $782.35M 24.83% | $836.52M 6.92% | Avg: $796.48M Low: $792.34M High: $803.98M avg. -4.78% | Avg: $850.55M Low: $844.58M High: $860.32M avg. 6.78% | ||
Net Income
% change YoY
| $91.30M N/A | $109.46M 19.88% | $107.47M -1.81% | Avg: $151.44M Low: $137.47M High: $165.63M avg. 40.91% | Avg: $164.21M Low: $159.95M High: $163.83M avg. 8.42% | ||
EBITDA
% change YoY
| $112.80M N/A | $167.07M 48.11% | $170.50M 2.05% | Avg: $153.09M Low: $152.30M High: $154.53M avg. -10.20% | Avg: $163.49M Low: $162.34M High: $165.37M avg. 6.78% | ||
EPS
% change YoY
| $4.37 N/A | $4.94 13.04% | $4.82 -2.42% | Avg: $6.77 Low: $6.2 High: $7.47 avg. 40.50% | Avg: $7.28 Low: $7.21 High: $7.39 avg. 7.49% | ||
Operating Expenses
% change YoY
| $88.92M N/A | $104.34M 17.33% | $156.09M 49.60% | Avg: $99.34M Low: $98.82M High: $100.27M avg. -36.36% | Avg: $106.08M Low: $105.33M High: $107.30M avg. 6.78% |
FAQ
What is MGP Ingredients stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 24.67% in 2025-2026.
We have gathered data from 5 analysts. Their low estimate is 137.47M, average is 151.44M and high is 165.63M.
What is MGP Ingredients stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 1.00% in 2025-2026.
We have gathered data from 5 analysts. Their low revenue estimate is $792.34M, average is $796.48M and high is $803.98M.
What is MGP Ingredients stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 24.00% in 2025-2026.
We have gathered data from 5 analysts. Their low earnings per share estimate is $6.2, average is $6.77 and high is $7.47.
What is the best performing analyst?
In the last twelve months 2 analysts have been covering MGP Ingredients stock. The most successful analyst is Bill Chappell.